Form 0920-0612 Attachment 3a WISEWOMAN MDE Version 9
Well-Integrated Screening and Evaluation for Women Across the Nation(WISEWOMAN) Reporting System
Attachment 3a WISEWOMAN MDE Version 9 00_08 08 2013
Combined MDE for Screening and Assessment MDE and Lifestyle Program MDE
OMB: 0920-0612
Form Approved
OMB No. 0920-0612
Exp. XX/XX/20XX
WISEWOMAN Program
MDE Manual
Version 9.0
July 2013
Public reporting burden of
this collection of information is estimated to average 24 hours per
response, including the time for reviewing instructions, searching
existing data sources, gathering and maintaining the data needed,
and completing and reviewing the collection of information. An
agency may not conduct or sponsor, and a person is not required to
respond to a collection of information unless it displays a
currently valid OMB control number. Send comments regarding this
burden estimate or any other aspect of this collection of
information, including suggestions for reducing this burden to
CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74,
Atlanta, Georgia 30333; ATTN: PRA (0920-0612).
CONTENTS
Item 1a: StFIPS |
State/Tribal FIPS Code This variable indicates the FIPS or tribal program code for the state or tribe where the administration of the program is located. |
SOURCE |
National FIPS Code List |
Denominator population |
The denominator includes all WISEWOMAN participants |
VALUES and description |
(State and Tribe values will be determined upon award of new funding) |
analysis and use |
To calculate the number of women screened by each state or tribal program To assess the reach of the WISEWOMAN Program nationally and within a particular state or tribe |
Item 1b: HdANSI |
ANSI Geographic Code (Provider) This indicates the ANSI geographic code of the provider that conducts the WISEWOMAN screening office visit. |
|
source |
National ANSI Code List, Census Bureau |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
ANSI Geographic Code |
Value representing the geographic area of the provider that conducts the screening office visit |
analysis and use |
To assess whether programs and specific providers are meeting screening goals in targeted geographic areas To identify geographic areas where women have access to the WISEWOMAN Program To provide information for GIS analysis To assist in identifying areas where there may be potential transportation barriers to accessing WISEWOMAN services |
|
Item 1c: EnrollSiteID |
Enrollment Site ID This variable indicates the site of a woman’s enrollment into the WISEWOMAN Program. |
|
source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Enrollment Site ID |
ID code of the enrollment site, as developed and assigned by the grantee |
analysis and use |
To identify sites where outreach and enrollment are occurring To identify sites where the Program is being administered and participants are tracked To track the number of WISEWOMAN participants enrolled at each WISEWOMAN enrollment site |
|
Item 1d: ScreenSiteID |
Screening Site ID This variable indicates the site where a woman received her WISEWOMAN screening. |
|
source |
National Provider Identifier |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Screening Site ID |
Value representing a National Provider Identifier for the provider who conducts the screening office visit |
analysis and use |
To identify the geographic locations of sites providing screening services to participants To track the number of WISEWOMAN participants screened at each WISEWOMAN screening site To describe differences in participant demographics or other characteristics by screening site To provide information for GIS analysis To identify the number of screening providers in a given geographic area To identify provider pool for assessment of health systems and providers that use clinical systems of care successful in blood pressure control |
|
Item 2a: TimePer |
Time Period of Screening This variable indicates the 6-month time period of the baseline screening for the participant. |
|
Source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
01 6-month period 1 |
Baseline screening took place between 07/01/13 and 12/31/13 |
02 6-month period 2 |
Baseline screening took place between 01/01/14 and 06/30/14 |
|
03 6-month period 1 |
Baseline screening took place between 07/01/14 and 12/31/14 |
|
04 6-month period 2 |
Baseline screening took place between 01/01/15 and 06/30/15 |
|
05 6-month period 1 |
Baseline screening took place between 07/01/15 and 12/31/15 |
|
06 6-month period 2 |
Baseline screening took place between 01/01/16 and 06/30/16 |
|
07 6-month period 1 |
Baseline screening took place between 07/01/16 and 12/31/16 |
|
08 6-month period 2 |
Baseline screening took place between 01/01/17 and 06/30/17 |
|
analysis and use |
To track participants over the course of the FOA by their baseline screenings To track the number of unique participants programs have screened |
|
Item 2b: NScreen |
Number of Screenings Received by the Participant This variable indicates the number of screenings/rescreenings the participant has received since the beginning of the FOA. |
|
Source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of Visits |
Value representing the number of screenings/rescreenings the participant has received since the beginning of the FOA (includes current screening) |
analysis and use |
To track the number of screenings/rescreenings that the participant has received |
|
Item 2c: Type |
Type of Screening Visit This variable indicates whether the record represents a baseline screening visit, a rescreening visit, or a post-Lifestyle Program (LSP)/Health Coaching (HC) follow-up assessment. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Screening |
Record represents a baseline screening visit |
|
2 Rescreening |
Record represents a rescreening visit |
|
3 Follow-up |
Record represents a post-LSP/HC follow-up assessment |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To assess the number of unique women served by the WISEWOMAN Program To track participants screening values over time To link baseline screenings with rescreenings To assess participants progress after completion of an LSP/HC |
|
Item 3a: EncodeID |
Unique Participant ID Number This variable indicates a woman’s unique identification number. |
|
source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Unique Participant ID Number |
Value representing the unique identifier for a participant |
analysis and use |
To assess the number of unique women served by the WISEWOMAN Program To track participants over time To link baseline screenings with rescreenings To link screenings with risk reduction counseling, lifestyle programs, health coaching, and community-based resource referrals |
|
Item 3b: ResANSI |
ANSI Geographic Code of Residence This variable indicates the ANSI geographic code of residence of the WISEWOMAN participant. |
|
source |
National ANSI Code List |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
ANSI Geographic Code |
Value representing the participant’s geographic area of residence
|
analysis and use |
To assess whether programs are meeting screening goals in targeted geographic areas To identify the reach of the WISEWOMAN Program To assist in identifying areas where there may be potential transportation barriers to accessing WISEWOMAN services |
|
Item 3c: ZIP |
ZIP Code of Residence This variable indicates the participant’s ZIP code of residence. |
|
Source |
National ZIP Code List |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
ZIP Code of Residence |
Valid five-digit (character) ZIP code |
|
99999 |
No ZIP code recorded |
analysis and use |
To assess whether programs are meeting screening goals in targeted geographic areas To identify the reach of the WISEWOMAN Program To identify participant county of residence outside program state boundaries |
|
Item 3d: MYB |
Month and Year of Birth This variable indicates the participant’s month and year of birth. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Month and Year of Birth |
Month and Year of Birth in MM01CCYY format Example: September 18, 1965 = 09011965 |
analysis and use |
To estimate the age of the participant To assist in characterizing the population reached by the WISEWOMAN Program To provide data element required to determine participant’s cardiovascular risk or risk score To assess whether the participants are within the Program’s priority age group |
|
Item 3e: Latino |
Hispanic or Latino Origin This variable indicates whether the participant is of Hispanic or Latino origin. |
|
SOURCE |
United States Office of Management and Budget Guidelines |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant reports that she is of Hispanic or Latino origin |
|
2 No |
Participant reports that she is not of Hispanic or Latino origin |
|
7 Unknown |
Participant is unsure whether she is of Hispanic or Latino origin |
|
9 No answer recorded |
Participant has not reported whether she is of Hispanic or Latino origin |
analysis and use |
To assess the race/ethnicity of WISEWOMAN participants To analyze screening, lifestyle programs, and other variables by ethnicity To assist in characterizing the population reached by the WISEWOMAN Program To provide data element required to determine participant’s cardiovascular risk or risk score |
|
Item 3f: Race1 |
Race: First Race This variable indicates a race with which the participant identifies. |
|
SOURCE |
United States Census Bureau; United States Office of Management and Budget Guidelines |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 White |
Participant identifies White as a race |
2 Black or African American |
Participant identifies Black or African American as a race |
|
3 Asian |
Participant identifies Asian as a race |
|
4 Native Hawaiian or Other Pacific Islander |
Participant identifies Native Hawaiian or Other Pacific Islander as a race |
|
5 American Indian or Alaska Native |
Participant identifies American Indian or Alaska Native as a race |
|
7 Unknown |
Participant does not know her race or does not identify with any of the races listed above If a participant is Hispanic and does not identify a race, this code should be used |
|
9 No answer recorded |
Race information is missing for the participant Any race information gathered should be entered beginning with the Race1 field. |
|
analysis and use |
To assess the race/ethnicity of WISEWOMAN participants To understand and analyze screening, lifestyle programs, and other variables by race To assist in characterizing the population reached by the WISEWOMAN Program To provide data element required to determine participant’s cardiovascular risk or risk score |
|
Item 3g: Race2 |
Race: Second Race This variable indicates a race with which the participant identifies in cases where a participant is multiracial. |
|
SOURCE |
United States Census Bureau; United States Office of Management and Budget Guidelines |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 White |
Participant identifies White as a race Participant who has identified two or more races can have this value |
2 Black or African American |
Participant identifies Black or African American as a race Participant who has identified two or more races can have this value |
|
3 Asian |
Participant identifies Asian as a race Participant who has identified two or more races can have this value |
|
4 Native Hawaiian or Other Pacific Islander |
Participant identifies Native Hawaiian or Other Pacific Islander as a race Participant who has identified two or more races can have this value |
|
5 American Indian or Alaska Native |
Participant identifies American Indian or Alaska Native as a race Participant who has identified two or more races can have this value |
|
7 Unknown |
Participant does not know her race or does not identify with any of the races listed above |
|
9 No answer recorded |
If race information is missing for Race2 Participant has not identified any race Participant has identified one race and does not identify other races If a participant does not identify a second race, ‘9 No answer recorded’ should be used for this field and all subsequent race fields |
|
analysis and use |
To assess the race/ethnicity of WISEWOMAN participants To understand and analyze screening, lifestyle programs, and other variables by race To assist in characterizing the population reached by the WISEWOMAN Program To provide data element required to determine participant’s cardiovascular risk or risk score |
|
Item 3h: Education |
Education (highest grade completed) This variable indicates the highest grade the participant completed. |
|
SOURCE |
CDC Behavioral Risk Factor Surveillance System |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 <9th grade |
Participant reports that she did not attend high school |
2 Some high school |
Participant reports she attended high school, but did not graduate |
|
3 High school graduate or equivalent |
Participant reports that she graduated from high school or has the equivalent of a high school diploma, and she did not attend any college or higher education |
|
4 Some college or higher |
Participant reports that she attended one or more years of college and/or graduate school (e.g., college graduate, graduate degree) |
|
7 Don’t know/Not sure |
Participant reports that she does not know the highest grade she completed |
|
8 Don’t want to answer |
Participant does not want to answer the highest grade she completed |
|
9 No answer recorded |
Education information is missing for the participant |
|
analysis and use |
To assess the educational attainment of women in the WISEWOMAN population To understand screening, lifestyle programs , and other variables by education status To help determine the literacy level needed for materials developed for recruitment, risk reduction counseling, lifestyle programs, health coaching, and community-based resources To assist in characterizing the population reached by the WISEWOMAN Program |
|
Item 3i: Language |
What is the primary language spoken in your home? This variable indicates the primary language spoken in the participant’s home. |
|
SOURCE |
National Survey of Children’s Health |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 English |
Participant identifies English as the primary language spoken in her home |
2 Spanish |
Participant identifies Spanish as the primary language spoken in her home |
|
3 Arabic |
Participant identifies Arabic as the primary language spoken in her home |
|
4 Chinese |
Participant identifies Chinese as the primary language spoken in her home |
|
5 French |
Participant identifies French as the primary language spoken in her home |
|
6 Italian |
Participant identifies Italian as the primary language spoken in her home |
|
7 Japanese |
Participant identifies Japanese as the primary language spoken in her home |
|
8 Korean |
Participant identifies Korean as the primary language spoken in her home |
|
9 Polish |
Participant identifies Polish as the primary language spoken in her home |
|
10 Russian |
Participant identifies Russian as the primary language spoken in her home |
|
11 Tagalog |
Participant identifies Tagalog as the primary language spoken in her home |
|
12 Vietnamese |
Participant identifies Vietnamese as the primary language spoken in her home |
|
13 Creole |
Participant identifies Creole as the primary language spoken in her home |
|
14 Portuguese |
Participant identifies Portuguese as the primary language spoken in her home |
|
15 Hmong |
Participant identifies Hmong as the primary language spoken in her home |
|
16 Other Language |
Participant identifies another language as the primary language spoken in her home (write-in response) |
|
88 Don’t want to answer |
Participant does not want to answer the primary language spoken in her home |
|
99 No answer recorded |
Primary language information is missing for the participant |
|
analysis and use |
To assess the primary language of women in the WISEWOMAN population To provide context to potential the health literacy issues To assist in characterizing the population reached by the WISEWOMAN Program |
|
Item 4a: SRHC |
Do you have high cholesterol? This variable indicates whether the participant has high cholesterol. |
|
Source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant has high cholesterol |
|
2 No |
Participant does not have high cholesterol |
|
7 Don’t know/Not sure |
Participant does not know whether she has high cholesterol The validation program will flag this value for a quality check |
|
8 Don’t want to answer |
Participant does not want to answer whether she has high cholesterol The validation tool will flag this value for a quality check |
|
9 No answer recorded |
No answer recorded The validation tool will flag this value as an error |
analysis and use |
To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To assess the number of cases of high cholesterol that have been previously diagnosed as opposed to newly detected cases among the WISEWOMAN population To assess control of and improvements in cholesterol for newly and previously diagnosed women |
|
Item 4b: SRHB |
Do you have hypertension (high blood pressure)? This variable indicates whether the participant has hypertension (high blood pressure). |
|
Source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant has hypertension (high blood pressure) |
|
2 No |
Participant does not have hypertension (high blood pressure) |
|
7 Don’t know/Not sure |
Participant does not know whether she has hypertension (high blood pressure) The validation program will flag this value for a quality check |
|
8 Don’t want to answer |
Participant does not want to answer whether she has hypertension (high blood pressure) The validation program will flag this value for a quality check |
|
9 No answer recorded |
No answer recorded The validation tool will flag this value as an error |
analysis and use |
To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To assess the number of cases of hypertension (high blood pressure) that have been previously diagnosed as opposed to newly detected cases among the WISEWOMAN population To assess control of and improvements in blood pressure for newly and previously diagnosed women |
|
Item 4c: SRD |
Do you have diabetes? (either Type 1 or Type 2) This variable indicates whether the participant has Type 1 or Type 2 diabetes. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant has Type 1 or Type 2 diabetes |
|
2 No |
Participant does not have Type 1 or Type 2 diabetes |
|
7 Don’t know/Not sure |
Participant does not know whether she has Type 1 or Type 2 diabetes |
|
8 Don’t want to answer |
Participant does not want to answer whether she has Type 1 or Type 2 diabetes |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To assess the number of cases of diabetes that have been previously diagnosed as opposed to newly detected cases among the WISEWOMAN population To assess control of and improvements in diabetes for newly and previously diagnosed women To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 4d: SRHA |
Have you been diagnosed by a healthcare provider as having any of these conditions: coronary heart disease/chest pain, heart attack, heart failure, stroke/transient ischemic attack (TIA), vascular disease, or congenital heart defects? This variable indicates whether the participant has ever been diagnosed by a healthcare provider as having coronary heart disease/chest pain, heart attack, heart failure, stroke/TIA, vascular disease, or congenital heart defects. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant has been diagnosed by a healthcare provider as having coronary heart disease/chest pain, heart attack, heart failure, stroke/TIA, vascular disease, or congenital heart defects |
|
2 No |
Participant has never been diagnosed by a healthcare provider as having coronary heart disease/chest pain, heart attack, heart failure, stroke/TIA, vascular disease, or congenital heart defects |
|
7 Don’t know/Not sure |
Participant does not know whether she has been diagnosed by a healthcare provider as having coronary heart disease/chest pain, heart attack, heart failure, stroke/TIA, vascular disease, or congenital heart defects |
|
8 Don’t want to answer |
Participant does not want to answer whether she has been diagnosed by a healthcare provider as having coronary heart disease/chest pain, heart attack, heart failure, stroke/TIA, vascular disease, or congenital heart defects |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To understand the history of cardiovascular disease among individual participants and the overall WISEWOMAN population To assess the number of participants who have been previously diagnosed as having cardiovascular disease To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 5a: HCMeds |
Do you take medication to lower your cholesterol? This variable indicates whether the participant takes medication to lower her cholesterol. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes WISEWOMAN participants with elevated cholesterol or previously diagnosed with high cholesterol |
|
VALUES and description |
1 Yes |
Participant is taking medication to lower her cholesterol |
|
2 No |
Participant is not taking medication to lower her cholesterol |
|
3 No – Could not obtain medication |
Participant is not taking medication to lower her cholesterol because she could not obtain the medication (e.g., could not obtain due to cost of medication, could not obtain due to expired prescription, could not obtain due to problems getting the prescription filled because of lack of transportation or access to a pharmacy) |
|
5 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with high cholesterol |
|
7 Don’t know/Not sure |
Participant does not know whether she is taking medication to lower her cholesterol |
|
8 Don’t want to answer |
Participant does not want to answer whether she is taking medication to lower her cholesterol |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To assess the number of cases of high cholesterol that have been previously diagnosed as opposed to newly detected cases among the WISEWOMAN population To assess the control and management of cholesterol among participants who have high cholesterol To assist in assessment of adherence to medication for high cholesterol |
|
Item 5b: HBPMeds |
Do you take medication to lower your blood pressure? This variable indicates whether the participant is taking medication to lower her blood pressure. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes WISEWOMAN participants with elevated blood pressure or previously diagnosed with hypertension (high blood pressure) |
|
VALUES and description |
1 Yes |
Participant is taking medication to lower her blood pressure |
|
2 No |
Participant is not taking medication to lower her blood pressure |
|
3 No – Could not obtain medication |
Participant is not taking medication to lower her blood pressure because she could not obtain the medication (e.g., could not obtain due to cost of medication, could not obtain due to expired prescription, could not obtain due to problems getting the prescription filled because of lack of transportation or access to a pharmacy) |
|
5 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with high blood pressure |
|
7 Don’t know/Not sure |
Participant does not know whether she is taking medication to lower her blood pressure |
|
8 Don’t want to answer |
Participant does not want to answer whether she is taking medication to lower her blood pressure |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To assess the number of cases of hypertension (high blood pressure) that have been previously diagnosed as opposed to newly detected cases among the WISEWOMAN population To assess the control and management of hypertension (high blood pressure) among participants who have hypertension (high blood pressure) To assist in assessment of adherence to medication for hypertension (high blood pressure) |
|
Item 5c: DMeds |
Are you taking medication to lower your blood sugar (for diabetes)? This variable indicates whether the participant is taking medication to lower her blood sugar for diabetes. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes WISEWOMAN participants with elevated blood glucose or A1C or previously diagnosed with diabetes |
|
VALUES and description |
1 Yes |
Participant is taking medication to lower her blood sugar for diabetes |
|
2 No |
Participant is not taking medication to lower her blood sugar for diabetes |
|
3 No – Could not obtain medication |
Participant is not taking medication to lower her blood sugar for diabetes because she could not obtain the medication (e.g., could not obtain due to cost of medication, could not obtain due to expired prescription, could not obtain due to problems getting the prescription filled because of lack of transportation or access to a pharmacy) |
|
5 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with high blood sugar for diabetes |
|
7 Don’t know/Not sure |
Participant does not know whether she is taking medication to lower her blood sugar for diabetes |
|
8 Don’t want to answer |
Participant does not want to answer whether she is taking medication to lower her blood sugar for diabetes |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To assess the number of cases of diabetes that have been previously diagnosed as opposed to newly detected cases among the WISEWOMAN population To assess diabetes control and management among participants who have diabetes To assist in assessment of adherence to medication for diabetes |
|
Item 5d: HCAdhere |
During the past 7 days (including today), on how many days did you take prescribed medication to lower your cholesterol? This variable indicates the number of days out of the past 7 days, including the day of the screening, that the participant took prescribed medication to lower her cholesterol. |
|
SOURCE |
Adapted from National Survey of Children’s Health |
|
Denominator population |
The denominator includes WISEWOMAN participants taking medication to lower cholesterol |
|
VALUES and description |
Number of days |
A one-digit (numeric) value indicating the number of days out of the past 7 days, including the day of the screening, that the participant took prescribed medication to lower her cholesterol |
|
0 None |
In the past 7 days, including the day of the screening, the participant did not take prescribed medication to lower her cholesterol |
|
55 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with high cholesterol |
|
77 Don’t know/Not sure |
Participant is not sure whether she took prescribed medication to lower her cholesterol during the past 7 days including the day of the screening |
|
88 Don’t want to answer |
Participant did not want to answer whether she took prescribed medication to lower her cholesterol during the past 7 days including the day of the screening |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To facilitate assessment of adherence to medication prescribed for high cholesterol To assist in determining high cholesterol management and control |
|
Item 5e: HBPAdhere |
During the past 7 days (including today), on how many days did you take prescribed medication (including diuretics/water pills) to lower your blood pressure? This variable indicates the number of days out of the past 7 days, including the day of the screening, that the participant took prescribed medication (including diuretics/water pills) to lower her blood pressure. |
|
SOURCE |
Adapted from National Survey of Children’s Health |
|
Denominator population |
The denominator includes WISEWOMAN participants taking medication to lower blood pressure |
|
VALUES and description |
Number of days |
A one-digit (numeric) value indicating the number of days out of the past 7 days, including the day of the screening, that the participant took prescribed medication (including diuretics/water pills) to lower her blood pressure |
|
0 None |
In the past 7 days, including the day of the screening, the participant did not take prescribed medication (including diuretics/water pills) to lower her blood pressure |
|
55 Not Applicable |
This question is not applicable for this patient because she has never been diagnosed with hypertension (high blood pressure) |
|
77 Don’t know/Not sure |
Participant is not sure whether she took prescribed medication (including diuretics/water pills) to lower her blood pressure during the past 7 days including the day of the screening |
|
88 Don’t want to answer |
Participant did not want to answer whether she prescribed medication (including diuretics/water pills) to lower her blood pressure during the past 7 days including the day of the screening |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To facilitate assessment of adherence to medication prescribed for hypertension (high blood pressure) To assist in determining hypertension (high blood pressure) prevention, management, and control |
|
Item 5f: DAdhere |
During the past 7 days (including today), on how many days did you take prescribed medication to lower blood sugar (for diabetes)? This variable indicates the number of days out of the past 7 days, including the day of the screening, that the participant took prescribed medication to lower her blood sugar (for diabetes). |
|
SOURCE |
Adapted from National Survey of Children’s Health |
|
Denominator population |
The denominator includes WISEWOMAN participants prescribed taking took prescribed medication to lower blood sugar |
|
VALUES and description |
Number of days |
A one-digit (numeric) value indicating the number of days out of the past 7 days, including the day of the screening, that the participant took prescribed medication to lower her blood sugar (for diabetes) |
|
0 None |
In the past 7 days, including the day of the screening, the participant did not take prescribed medication to lower her blood sugar (for diabetes) |
|
55 Not Applicable |
This question is not applicable for this patient because she has never been diagnosed with high blood sugar (for diabetes) |
|
77 Don’t know/Not sure |
Participant is not sure whether she took prescribed medication to lower her blood sugar (for diabetes) during the past 7 days including the day of the screening |
|
88 Don’t want to answer |
Participant did not want to answer whether she took prescribed medication to lower her blood sugar (for diabetes) during the past 7 days including the day of the screening |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To facilitate assessment of adherence to medication prescribed for diabetes To assist in determining diabetes control and management |
|
Item 6a: BPHome |
Do you measure your blood pressure at home or using other calibrated sources? This variable indicates whether the participant monitors her blood pressure at home or using other calibrated sources (select all response options that apply). |
|
SOURCE |
HealthStyles Survey |
|
Denominator population |
The denominator includes WISEWOMAN participants with elevated blood pressure or those with elevated blood pressure taking medication |
|
VALUES and description |
1 Yes |
Participant reports that she measures her blood pressure at home or using other calibrated sources |
|
2 No – Was never told to measure her blood pressure |
Participant reports that she does not measure her blood pressure at home or using other calibrated sources because she was never told she should measure her blood pressure |
|
3 No – Doesn’t know how to measure her blood pressure |
Participant reports that she does not measure her blood pressure at home or using other calibrated sources because she does not know how to measure her blood pressure |
|
4 No – Doesn’t have equipment to measure her blood pressure |
Participant reports that she does not measure her blood pressure at home or using other calibrated sources because she does not have access to the required equipment to measure her blood pressure |
|
5 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with hypertension (high blood pressure) or does not monitor her blood pressure at home or using other calibrated sources |
|
7 Don’t know/Not sure |
Participant is not sure whether she measures her blood pressure at home or using other calibrated sources |
|
8 Don’t want to answer |
Participant did not want to answer whether she measures her blood pressure at home or using other calibrated sources |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine self-control and management of hypertension (high blood pressure) |
|
Item 6b: BPFreq |
How often do you measure your blood pressure at home or using other calibrated sources? This variable indicates how frequently the participant measures her blood pressure at home or using other calibrated sources. |
|
SOURCE |
HealthStyles Survey |
|
Denominator population |
The denominator includes WISEWOMAN participants with elevated blood pressure or those with elevated blood pressure taking medication who have indicated they measure their blood pressure at home or using other calibrated sources |
|
VALUES and description |
1 Multiple times per day |
Participant measures her blood pressure at home or using other calibrated sources multiple times per day |
|
2 Daily |
Participant measures her blood pressure at home or using other calibrated sources once per day |
|
3 A few times per week |
Participant measures her blood pressure at home or using other calibrated sources a few times per week |
|
4 Weekly |
Participant measures her blood pressure at home or using other calibrated sources once per week |
|
5 Monthly |
Participant measures her blood pressure at home or using other calibrated sources once per month |
|
6 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with hypertension (high blood pressure) or does not monitor her blood pressure at home or using other calibrated sources |
|
7 Don’t know/Not sure |
Participant is not sure how frequently she measures her blood pressure at home or using other calibrated sources |
|
8 Don’t want to answer |
Participant did not want to answer how frequently she measures her blood pressure at home or using other calibrated sources |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine self-control and management of hypertension (high blood pressure) |
|
Item 6c: BPSend |
Do you regularly share blood pressure readings with a health care provider for feedback? This variable indicates whether the participant shares blood pressure readings taken at home or using other calibrated sources with a health care provider for feedback almost every time she sees her provider. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes WISEWOMAN participants with elevated blood pressure or those with elevated blood pressure taking medication who have indicated they measure their blood pressure at home or using other calibrated sources |
|
VALUES and description |
1 Yes |
Participant reports that she shares blood pressure readings taken at home or using other calibrated sources with a health care provider for feedback almost every time she sees her provider |
|
2 No |
Participant reports that she does not share blood pressure readings taken at home or using other calibrated sources with a health care provider for feedback |
|
5 Not Applicable |
This question is not applicable for the patient because she has never been diagnosed with hypertension (high blood pressure) or does not monitor her blood pressure at home or using other calibrated sources |
|
7 Don’t know/Not sure |
Participant is not sure whether she shares blood pressure readings taken at home or using other calibrated sources with a health care provider for feedback |
|
8 Don’t want to answer |
Participant did not want to answer whether she shares blood pressure readings taken at home or using other calibrated sources with a health care provider for feedback |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine self-control and management of hypertension (high blood pressure) To determine whether blood pressure monitoring results are shared with a health care provided for monitoring of progress |
|
Item 7a: Fruit |
How much fruit do you eat in an average day? This variable indicates the amount of fruit the participant consumes in an average day. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of cups |
Two-digit (numeric) value representing the number of cups of fruit the participant consumes in an average day |
|
00 None |
Participant does not consume fruit in an average day |
|
88 Don’t want to answer |
Participant does not want to answer how many cups of fruit she consumes in an average day |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 7b: Vegetables |
How many vegetables do you eat in an average day? This variable indicates the amount of vegetables the participant consumes in an average day. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of cups |
Two-digit (numeric) value representing the number of cups of vegetables the participant consumes in an average day |
|
00 None |
Participant does not consume vegetables in an average day |
|
88 Don’t want to answer |
Participant does not want to answer how many cups of vegetables she consumes in an average day |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 7c: Fish |
Do you eat two servings or more of fish weekly? This variable indicates whether the participant consumes two servings or more of fish weekly. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant consumes two servings or more of fish weekly |
|
2 No |
Participant does not consume two servings or more of fish weekly |
|
8 Don’t want to answer |
Participant does not want to answer whether she consumes two servings or more of fish weekly |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 7d: Grains |
Do you eat 3 ounces or more of whole grains daily? This variable indicates whether the participant consumes 3 ounces or more of whole grains daily. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant consumes 3 ounces or more of whole grains daily |
|
2 No |
Participant does not consume 3 ounces or more of whole grains daily |
|
8 Don’t want to answer |
Participant does not want to answer whether she consumes 3 ounces or more of whole grains daily |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 7e: Sugar |
Do you drink less than 36 ounces (450 calories) of beverages with added sugars weekly? This variable indicates whether the participant drinks less than 36 ounces (450calories) of beverages with added sugars weekly. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant consumes less than 36 ounces (450 calories) of beverages with added sugars in an average week |
|
2 No |
Participant consumes 36 ounces or more (450 calories or more) of beverages with added sugars in an average week |
|
8 Don’t want to answer |
Participant does not want to answer whether she consumes less than 36 ounces (450 calories) or more of beverages with added sugars in an average week |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 7f: SaltCon |
Do you eat 1,500 mg of sodium or less daily? This variable indicates whether the participant consumes 1,500 mg of sodium or less daily. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant consumes 1,500 mg of sodium or less daily |
|
2 No |
Participant consumes more than 1,500 mg of sodium daily |
|
8 Don’t want to answer |
Participant does not want to answer whether she consumes 1,500 mg of sodium or less daily |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 7g: SaltWatch |
Are you currently watching or reducing your sodium or salt intake? This variable indicates whether the participant is currently watching or reducing her sodium or salt intake. |
|
SOURCE |
CDC Behavioral Risk Factor Surveillance System |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant is currently watching or reducing her sodium or salt intake |
|
2 No |
Participant is not currently watching or reducing her sodium or salt intake |
|
8 Don’t want to answer |
Participant does not want to answer whether she is currently watching or reducing her sodium or salt intake |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population |
|
Item 8a: PAMod |
How much moderate physical activity do you get in a week? This variable indicates the amount of moderate physical activity the participant gets during an average week. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of minutes |
A three-digit (numeric) value representing the minutes of moderate physical activity the participant gets during an average week |
|
000 None |
Participant does not get any moderate physical activity during an average week |
|
888 Don’t want to answer |
Participant does not want to answer how much moderate physical activity she gets during an average week |
|
999 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 8b: PAVig |
How much vigorous physical activity do you get in a week? This variable indicates the amount of vigorous physical activity the participant gets during an average week. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of minutes |
A three-digit (numeric) value representing the minutes of vigorous physical activity the participant gets during an average week |
|
000 None |
Participant does not get any vigorous physical during an average week |
|
888 Don’t want to answer |
Participant does not want to answer how much vigorous physical activity she gets during an average week |
|
999 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 9a: Smoker |
Do you smoke? Includes cigarettes, pipes, or cigars (smoked tobacco in any form) This variable indicates whether the participant smokes tobacco in any form, including cigarettes, pipes, or cigars. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Current Smoker |
Participant currently smokes tobacco in any form, including cigarettes, pipes, or cigars |
|
2 Quit (1-12 months ago) |
Participant quit smoking tobacco in any form, including cigarettes, pipes, or cigars, 1 to 12 months ago |
|
3 Quit (More than 12 months ago) |
Participant quit smoking tobacco in any form, including cigarettes, pipes, or cigars, more than 12 months ago |
|
4 Never Smoked |
Participant has never smoked tobacco in any form, including cigarettes, pipes, or cigars |
|
8 Don’t want to answer |
Participant does not want to answer whether she smokes tobacco in any form, including cigarettes, pipes, or cigars |
|
9 No answer recorded |
No answer recorded |
analysis and use |
To determine the healthy and risky behaviors of individual participants and the overall WISEWOMAN population To identify participants who might benefit from smoking cessation counseling and tobacco cessation resources (quit line and community-based) To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 9b: Sechand |
About how many hours a day, on average, are you in the same room or vehicle with another person who is smoking? This variable indicates how many hours a day, on average, the participant is in the same room or vehicle as another person who is smoking. |
|
SOURCE |
Pregnancy Risk Assessment Monitoring System |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of hours |
A two-digit (numeric) value indicating the number of hours per day, on average, the participant is in the same room or vehicle as another person who is smoking |
|
66 Less than one |
Participant is in the same room or vehicle with another person who is smoking less than one hour per day, on average |
|
00 None |
Participant is never in the same room or vehicle as another person who is smoking |
|
88 Don’t want to answer |
Participant does not want to answer the number of hours per day, on average, that she is in the same room or vehicle as another person who is smoking |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To determine the exposure of individual participants and the overall WISEWOMAN population to risks in the environment To help assess use of community-based referral resources and risk reduction counseling for those exposed to secondhand smoke |
|
Item 10a: QOLPH |
Thinking about your physical health, which includes physical illness and injury, on how many days during the past 30 days was your physical health not good? This variable indicates the number of days during the past 30 days that the participant’s physical health, including physical illness and injury, was not good. |
|
SOURCE |
CDC Health-Related Quality of Life Measures |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of days |
A two-digit (numeric) value representing the number of days during the past 30 days that the participant’s physical health, including physical illness and injury, was not good |
|
77 Don’t know/Not sure |
Participant does not know how many days during the past 30 days that her physical health, including physical illness and injury, was not good |
|
88 Don’t want to answer |
Participant does not want to answer how many days during the past 30 days that her physical health, including physical illness and injury, was not good |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To determine the health status of individual participants and the overall WISEWOMAN population To provide health status information for cost benefit or cost effectiveness analyses |
|
Item 10b: QOLMH |
Thinking about your mental health, which includes stress, depression, and problems with emotions, on how many days during the past 30 days was your mental health not good? This variable indicates the number of days during the past 30 days that the participant’s mental health, including stress, depression, and problems with emotions, was not good. |
|
SOURCE |
CDC Health-Related Quality of Life Measures |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of days |
A two-digit (numeric) value representing the number of days during the past 30 days that the participant’s mental health, including stress, depression, and problems with emotions, was not good |
|
77 Don’t know/Not sure |
Participant does not know how many days during the past 30 days that the participant’s mental health, including stress, depression, and problems with emotions, was not good |
|
88 Don’t want to answer |
Participant does not want to answer how many days during the past 30 days that the participant’s mental health, including stress, depression, and problems with emotions, was not good |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To determine the health status of individual participants and the overall WISEWOMAN population To provide health status information for cost benefit or cost effectiveness analyses |
|
Item 10c: QOLEffect |
During the past 30 days, on about how many days did poor physical or mental health keep you from doing your usual activities, such as self-care, work, or recreation? This variable indicates the number of days during the past 30 days that the participant’s poor physical or mental health kept her from doing her usual activities, such as self-care, work, or recreation. |
|
SOURCE |
CDC Health-Related Quality of Life Measures |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Number of days |
A two-digit (numeric) value representing the number of days during the past 30 days that the participant’s poor physical or mental health kept her from doing her usual activities, such as self-care, work, or recreation |
|
77 Don’t know/Not sure |
Participant does not know how many days during the past 30 days that the participant’s poor physical or mental health kept her from doing her usual activities, such as self-care, work, or recreation |
|
88 Don’t want to answer |
Participant does not want to answer how many days during the past 30 days that the participant’s poor physical or mental health kept her from doing her usual activities, such as self-care, work, or recreation |
|
99 No answer recorded |
No answer recorded |
analysis and use |
To determine the health status of individual participants and the overall WISEWOMAN population To provide health status information for cost benefit or cost effectiveness analyses |
|
Item 11a: Height |
Height This variable indicates the participant’s height in inches. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Height in inches |
Up to a two-digit (numeric) value representing the participant’s height |
|
777 Unable to obtain |
Height measurement was attempted, but measurement results were not obtained |
|
888 Client refused |
Participant refuses to have her height measurement taken |
|
999 No measurement recorded |
Height measurement was not performed
|
analysis and use |
To calculate the BMI of WISEWOMAN participants To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 11b: Weight |
Weight This variable indicates the participant’s weight in pounds. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Weight in pounds |
Up to a three-digit (numeric) value representing the participant’s weight |
|
777 Unable to obtain |
Weight measurement was attempted, but measurement results were not obtained |
|
888 Client refused |
Participant refuses to have her weight measurement taken
|
|
999 No measurement recorded |
Weight measurement was not performed
|
analysis and use |
To calculate the BMI of WISEWOMAN participants To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 11c: Waist |
Waist Circumference This variable indicates the participant’s waist circumference in inches. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Waist Circumference in inches |
Up to a two-digit (numeric) value representing the participant’s waist circumference in inches |
|
777 Unable to obtain |
Waist circumference measurement was attempted, but measurement results were not obtained |
|
888 Client refused |
Participant refuses to have her waist circumference measurement taken |
|
999 No measurement recorded |
Waist circumference measurement was not performed |
analysis and use |
To determine waist-hip ratio for the participant To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population |
|
Item 11d: Hip |
Hip Circumference This variable indicates the participant’s hip circumference in inches. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Hip Circumference in inches |
Up to a two-digit (numeric) value representing the participant’s hip circumference in inches |
|
777 Unable to obtain |
Hip circumference measurement was attempted, but measurement results were not obtained |
|
888 Client refused |
Participant refuses to have her hip circumference measurement taken |
|
999 No measurement recorded |
Hip circumference measurement was not performed |
analysis and use |
To determine waist-hip ratio for the participant To understand the cardiovascular disease risk factors of individual participants and the overall WISEWOMAN population |
|
Item 12a: BPDate |
Blood Pressure Measurement Date (Office Visit Date) This variable indicates the date of the office visit when a blood pressure measurement is obtained. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Blood pressure measurement date/Office visit date |
Valid date in MMDDCCYY format Date of the office visit and when a blood pressure measurement is obtained |
analysis and use |
To identify the date of the office visit and blood pressure measurements To facilitate analysis of changes in blood pressure over time To calculate other service time frames, including time to rescreening, lifestyle program sessions, lifestyle program/health coaching follow-up screening, risk reduction counseling sessions, alert referrals, and labs |
|
Item 12b: SBP1 |
Systolic Blood Pressure #1 This variable indicates the participant’s first systolic blood pressure reading. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Systolic blood pressure in mmHg |
Up to a three-digit (numeric) value representing the participant’s first systolic blood pressure in mmHg |
|
777 Unable to obtain |
First systolic blood pressure measurement was attempted, but results were not obtained due to technical difficulties or errors |
|
888 Client refused |
Participant refuses to have her first systolic blood pressure measurement taken |
|
999 No measurement recorded |
First systolic blood pressure measurement was not performed or not recorded |
analysis and use |
To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure, stroke, and kidney disease To identify participants who would benefit from lifestyle programs To identify participants unaware that they have hypertension (high blood pressure) for referral to medical management To determine control and management of blood pressure To identify participants who require further diagnostic evaluation To identify hypertension (high blood pressure) risk of the WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 12c: DBP1 |
Diastolic Blood Pressure #1 This variable indicates the participant’s first diastolic blood pressure reading. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Diastolic blood pressure in mmHg |
Up to a three-digit (numeric) value representing the participant’s diastolic blood pressure in mmHg |
|
777 Unable to obtain |
First diastolic blood pressure measurement was attempted, but results were not obtained due to technical difficulties or errors |
|
888 Client refused |
Participant refuses to have her first diastolic blood pressure measurement taken |
|
999 No measurement recorded |
First diastolic blood pressure measurement was not performed or not recorded |
analysis and use |
To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure, stroke, and kidney disease To identify participants who would benefit from lifestyle programs To identify participants unaware that they have hypertension(high blood pressure) for referral to medical management To determine control and management of blood pressure To identify participants who require further diagnostic evaluation To identify hypertension (high blood pressure) risk of the WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 12d: SBP2 |
Systolic Blood Pressure #2 This variable indicates the participant’s second systolic blood pressure reading. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Systolic blood pressure in mmHg |
Up to a three-digit (numeric) value representing the participant’s second systolic blood pressure in mmHg |
|
777 Unable to obtain |
Second systolic blood pressure measurement was attempted, but results were not obtained due to technical difficulties or errors |
|
888 Client refused |
Participant refuses to have her second systolic blood pressure measurement taken |
|
999 No measurement recorded |
Second systolic blood pressure measurement was not performed or not recorded |
analysis and use |
To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure, stroke, and kidney disease To identify participants who would benefit from lifestyle programs To identify participants unaware that they have hypertension (high blood pressure) for referral to medical management To determine control and management of blood pressure among those currently being treated To identify participants who require further diagnostic evaluation To identify hypertension (high blood pressure) risk in the WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 12e: DBP2 |
Diastolic Blood Pressure #2 This variable indicates the participant’s second diastolic blood pressure reading. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Diastolic blood pressure in mmHg |
Up to a three-digit (numeric) value representing the participant’s diastolic blood pressure in mmHg |
|
777 Unable to obtain |
Second diastolic blood pressure measurement was attempted, but results were not obtained due to technical difficulties or errors |
|
888 Client refused |
Participant refuses to have her second diastolic blood pressure measurement taken |
|
999 No measurement recorded |
Second diastolic blood pressure measurement was not performed or not recorded |
analysis and use |
To identify those at increased risk for cardiovascular conditions, including heart attack, heart failure, stroke, and kidney disease To identify participants who would benefit from lifestyle programs To identify participants unaware that they have hypertension (high blood pressure) for referral to medical management To determine control and management of blood pressure To identify participants who require further diagnostic evaluation To identify hypertension (high blood pressure) risk of the WISEWOMAN population To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 13a: Fast |
Fasting Status This variable indicates whether a participant fasted for at least nine hours prior to having blood drawn for cholesterol or glucose measurements. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Yes |
Participant fasted for at least nine hours prior to having blood drawn |
|
2 No |
Participant did not fast for at least nine hours prior to having blood drawn |
|
9 No answer recorded |
No answer recorded Provider failed to confirm fasting status or no information is available from the provider |
analysis and use |
To facilitate accurate identification of participants who have high cholesterol, borderline high cholesterol, diabetes, or pre-diabetes |
|
Item 14a: TCDate |
Cholesterol Measurement Date This variable indicates the date that the cholesterol measurements were taken. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Screening Date |
Valid date in MMDDCCYY format The date recorded in this field must be the date that the total and HDL cholesterol values were taken; total cholesterol and HDL measurements are minimum requirements for every participant If
a lipid panel is completed as part of the screening process, the
|
analysis and use |
To determine the date of the cholesterol measurements To facilitate analysis of changes in control and management of cholesterol over time |
|
Item 14b: TotChol |
Total Cholesterol (fasting or nonfasting) This variable indicates the participant’s total cholesterol level. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Total cholesterol in mg/dL |
Up to a three-digit (numeric) value representing the participant’s total cholesterol in mg/dL |
|
777 Inadequate blood sample |
Total cholesterol measurement was attempted, but results were not obtained due to technical difficulties or errors This may include issues such as (1) two or more failed venipuncture attempts; (2) insufficient amount of blood, type of test tube; (3) sample submitted to laboratory, test not done due to erroneous or missing laboratory request or other paperwork |
|
888 Client refused |
Participant refuses to have her blood drawn for cholesterol measurements If the participant refuses to go to the lab, the participant can be considered to have refused If the participant does not go to the scheduled lab appointment after follow-up has been attempted, the participant can be considered to have refused |
|
999 No measurement recorded |
No total cholesterol measurement was taken or recorded
|
analysis and use |
To identify participants who are unaware that they have high or borderline high cholesterol and need preventive services or referral to medical management To determine cholesterol control and management To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline high cholesterol To assess the risk in the WISEWOMAN population for cardiovascular disease To provide data element required to determine participant’s Simple 7 cardiovascular risk score |
|
Item 14c: HDL |
HDL Cholesterol (fasting or nonfasting) This variable indicates the participant’s HDL cholesterol level. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
HDL cholesterol in mg/dL |
Up to a three-digit (numeric) value representing the participant’s HDL cholesterol in mg/dL |
|
777 Inadequate blood sample |
HDL cholesterol measurement was attempted, but results were not obtained due to technical difficulties or errors This may include issues such as (1) two or more failed venipuncture attempts; (2) insufficient amount of blood, type of test tube; (3) sample submitted to laboratory, test not done due to erroneous or missing laboratory request or other paperwork |
|
888 Client refused |
Participant refuses to have her blood drawn for cholesterol measurements If the participant refuses to go to the lab, the participant can be considered to have refused If the participant does not go to the scheduled lab appointment after follow-up has been attempted, the participant can be considered to have refused |
|
999 No measurement recorded |
No HDL cholesterol measurement was taken or recorded
|
analysis and use |
To identify participants who are unaware that they have low HDL cholesterol and need preventive services or referral to medical management To assess the percentage of WISEWOMAN participants who have high cholesterol or borderline high cholesterol To assess the risk of the WISEWOMAN population for cardiovascular disease To assist in determining cholesterol control and management |
|
Item 14d: LDL |
LDL Cholesterol (fasting) This variable indicates a fasting participant’s fasting LDL cholesterol level. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
LDL cholesterol in mg/dL |
Up to a three-digit (numeric) value representing a fasting participant’s fasting LDL cholesterol in mg/dL
|
|
777 Inadequate blood sample |
LDL cholesterol measurement was attempted, but results were not obtained due to technical difficulties or errors This may include issues such as (1) two or more failed venipuncture attempts; (2) insufficient amount of blood, type of test tube; (3) sample submitted to laboratory, test not done due to erroneous or missing laboratory request or other paperwork This response should be used for participants who were confirmed to be fasting, but their LDL cholesterol was unable to be obtained
|
|
888 Client refused |
Participant refuses to receive a lipid panel that would include LDL measurements This response should be used for participants who were confirmed to be fasting, but refused a lipid panel
|
|
999 No measurement recorded |
No LDL cholesterol measurement was taken or recorded Nonfasting participants should always have this value |
analysis and use |
To assist in determining cholesterol control and management |
|
Item 14e: Trigly |
Triglycerides (fasting) This variable indicates a fasting participant’s triglycerides measurement. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Triglycerides in mg/dL |
Up to a four-digit (numeric) value representing a fasting participant’s triglycerides measurement in mg/dL |
|
7777 Inadequate blood sample |
Triglycerides measurement was attempted, but results were not obtained due to technical difficulties or errors This may include issues such as (1) two or more failed venipuncture attempts; (2) insufficient amount of blood, type of test tube; (3) sample submitted to laboratory, test not done due to erroneous or missing laboratory request or other paperwork This response should be used for participants who were confirmed to be fasting, but their triglycerides measurement could not be obtained |
|
8888 Client refused |
Fasting participant refuses to receive a lipid panel that would include triglycerides measurements This response should be used for participants who were confirmed to be fasting, but refused a lipid panel |
|
9999 No measurement recorded |
No triglycerides measurement was taken or recorded Nonfasting participants should always have this value |
analysis and use |
To assist in determining cholesterol control and management |
|
Item 15a: BGDate |
Glucose/A1c Measurement Date This variable indicates the date that the glucose or A1C measurements were taken. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Screening Date |
Valid date in MMDDCCYY format |
analysis and use |
To determine the date of the glucose or A1C measurements To facilitate analysis of changes in glucose or A1C measurements over time |
|
Item 15b: Glucose |
Glucose (fasting) This variable indicates the participant’s fasting glucose measurement. |
|
SOURCE |
American Heart Association Life’s Simple 7 |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Total glucose in mg/dL |
Up to a three-digit (numeric) value representing the participant’s fasting glucose level in mg/dL
|
|
777 Inadequate blood sample |
Glucose measurement was attempted, but results were not obtained due to technical difficulties or errors |
|
888 Client refused |
Participant refuses to have her blood drawn for glucose measurements If the participant refuses to go to the lab, the participant can be considered to have refused If the participant does not go to the scheduled lab appointment after follow-up has been attempted, the participant can be considered to have refused |
|
999 No measurement recorded |
No glucose measurement was taken or record |
analysis and use |
To identify participants who have pre-diabetes and diabetes To assist in determining diabetes control and management To use in conjunction with A1C percentage (14c: A1C) to accurately assess a participant’s blood glucose To provide data element required to determine participant’s Simple 7 cardiovascular risk score To understand the overall rate of diabetes among the WISEWOMAN population |
|
Item 15c: A1C |
A1C Percentage This variable indicates the participant’s A1C percentage (if measured). |
|
Source |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
A1C percentage |
Numeric value representing the participant’s A1C percentage. A1C should be reported to one decimal point If A1C was measured by another provider within the last 3 months, it is acceptable to input the value if it is available |
|
7777 Inadequate blood sample |
A1C measurement was attempted, but results were not obtained due to technical difficulties or errors |
|
8888 Client refused |
Participant refuses to have an A1C test If a participant refuses to go to the lab, the participant can be considered to have refused If a participant does not go to the scheduled lab appointment after follow-up has been attempted, the participant can be considered to have refused |
|
9999 No measurement recorded |
No A1C measurement was taken or recorded
|
analysis and use |
To identify participants who have diabetes and refer them for medical management To identify participants who have higher-than-optimal A1C levels and would benefit from preventive services such as lifestyle programs To assist in determining diabetes control and management To assess the cardiovascular disease risk factors in the WISEWOMAN population |
|
Item 16a: BPAlert |
If average SBP >180 or DBP >110, what is the status of the workup? This variable indicates the status of the workup of a participant’s alert level blood pressure. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Workup complete |
Workup for participant with an alert level blood pressure reading is complete |
|
2 Follow-up – workup by alternate provider |
Patient intends to see an alternate provider within 7 days |
|
3 Not an alert reading |
Participant did not have an alert level blood pressure reading |
|
8 Client refused workup |
Participant had an alert level blood pressure reading but refused workup |
|
9 Workup not completed, client lost to follow-up |
Participant had an alert level blood pressure reading but was lost to follow-up, and workup was not completed Lost to follow-up is defined as a participant who did not attend her scheduled workup within three months after a screening visit and could not be reached to reschedule another appointment |
analysis and use |
To assess whether participants with alert level blood pressure readings are receiving a workup To assist in determining hypertension (high blood pressure) management, and control |
|
Item 16b: BPDiDate |
If Average SBP >180 or DBP >110, Workup Date This variable indicates the workup date for a participant with an alert level blood pressure reading. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
Participants who have an alert level blood pressure value are included in the denominator |
|
VALUES and description |
Blood Pressure Workup Date |
Valid date in MMDDCCYY format If follow-up information is provided for this referral, the workup date can be entered |
analysis and use |
To assess whether providers are performing timely workups for participants with alert level blood pressure values To determine whether programs are meeting the guideline of workups within one week of the screening for alert participants To assist in determining hypertension (high blood pressure) prevention, management, and control |
|
Item 16c: BGAlert |
If GLUCOSE ≤50 or GLUCOSE ≥250, what is the status of the workup? This variable indicates the status of the workup of a participant’s alert level blood glucose. |
|
SOURCE |
Not applicable; health screening measurement |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Workup complete |
Workup for participant with an alert level fasting glucose reading is complete |
|
2 Follow-up – work up by alternate provider |
Patient intends to see an alternate provider within 7 days |
|
3 Not an alert reading |
Participant does not have an alert level fasting glucose reading |
|
8 Client refused workup |
Participant had an alert level fasting glucose reading but refused workup |
|
9 Workup not completed, client lost to follow-up |
Participant had an alert level fasting glucose reading but was lost to follow-up, and workup was not completed Lost to follow-up is defined as a participant who did not attend her scheduled workup within three months after a screening visit and was unable to be reached to reschedule another appointment |
analysis and use |
To assess whether participants with alert level blood glucose readings are receiving workup To assist in determining diabetes prevention, management, and control |
|
Item 16d: BGDiDate |
If GLUCOSE ≤50 or GLUCOSE ≥250 Workup Exam Date This variable indicates the workup date for a participant with an alert level fasting blood glucose reading. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
Participants who have alert level fasting glucose values are included in the denominator. |
|
VALUES and description |
Blood glucose workup date |
Valid date in MMDDCCYY format If follow-up information is provided for this referral, the workup date can be entered |
analysis and use |
To assess whether providers are performing timely workups for participants with alert level fasting blood glucose values To determine whether programs are meeting the guideline of workup within one week of the screening for alert participants |
|
Item 17a: RRCDate |
Risk Reduction Counseling Date This variable indicates the date that the initial risk reduction counseling occurred. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Risk reduction counseling date |
Valid date in MMDDCCYY format Date must occur within the submission period |
analysis and use |
To determine the date of the risk reduction counseling To assess receipt of risk reduction counseling to inform analyses of behavior change To facilitate analysis of changes in risk reduction counseling provision over time |
|
Item 17b: RRCComplete |
Risk Reduction Counseling Completion Date This variable indicates the date that risk reduction counseling was completed. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Risk reduction counseling follow-up date |
Valid date in MMDDCCYY format Date must occur within the submission period |
analysis and use |
To determine the date of a completed risk reduction counseling session To facilitate analysis of changes in risk reduction counseling provision over time |
|
Item 17c: RRCNut |
Participant Decided Nutrition Is A Priority Area This variable indicates whether the participant decided that nutrition is a priority area after receiving risk reduction counseling. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants that received risk reduction counseling |
|
VALUES and description |
1 Yes |
Participant decided that nutrition is a priority area |
|
2 No |
Participant did not decide that nutrition is a priority area |
|
7 Unknown |
It is unknown whether the participant decided that nutrition is a priority area |
analysis and use |
To determine the number of participants that decided nutrition is a priority area after receiving risk reduction counseling To assist in determining participant health education on cardiovascular disease risk factors To assist in assessments of reduction of risk over time in context of types of counseling received |
|
Item 17d: RRCPA |
Participant Decided Physical Activity Is A Priority Area This variable indicates whether the participant decided that physical activity is a priority area after receiving risk reduction counseling. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants that received risk reduction counseling |
|
VALUES and description |
1 Yes |
Participant decided that physical activity is a priority area |
|
2 No |
Participant did not decide that physical activity is a priority area |
|
7 Unknown |
It is unknown whether the participant decided that physical activity is a priority area |
analysis and use |
To determine the number of participants that decided physical activity is a priority area after receiving risk reduction counseling To assist in determining participant health education on cardiovascular disease risk factors To assist in assessments of reduction of risk over time in context of types of counseling received |
|
Item 17e: RRCSmoke |
Participant Decided Smoking Cessation Is A Priority Area This variable indicates whether the participant decided that smoking cessation is a priority area after receiving risk reduction counseling. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants that have received risk reduction counseling and are smokers and those exposed to second hand smoke |
|
VALUES and description |
1 Yes |
Participant decided that smoking cessation is a priority area |
|
2 No |
Participant did not decide that smoking cessation is a priority area |
|
7 Unknown |
It is unknown whether the participant decided that smoking cessation is a priority area |
analysis and use |
To determine the number of participants that decided smoking cessation is a priority area after receiving risk reduction counseling To assist in determining participant health education on cardiovascular disease risk factors To assist in assessments of reduction of risk over time in context of types of counseling received |
|
Item 17f: RRCMedAdhere |
Participant Decided Medication Adherence for Hypertension (high blood pressure) Is A Priority Area This variable indicates whether the participant decided medication adherence for her hypertension (high blood pressure) is a priority area after receiving risk reduction. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants taking medication for hypertension (high blood pressure) and received risk reduction counseling |
|
VALUES and description |
1 Yes |
Participant decided that medication adherence for hypertension (high blood pressure) is a priority area |
2 No |
Participant did not decide that medication adherence for hypertension (high blood pressure) is a priority area |
|
|
7 Unknown |
It is unknown whether the participant decided that medication adherence for hypertension (high blood pressure) is a priority area |
analysis and use |
To determine the number of participants that decided that medication adherence for hypertension (high blood pressure) is a priority area after receiving risk reduction counseling To assist in determining hypertension (high blood pressure) prevention, management, and control To assist in determining participant health education on cardiovascular disease risk factors To assist in assessments of reduction of risk over time in context of types of counseling received |
|
Item 18a: RTCDate |
Readiness to Change Assessment Date This variable indicates the date that an assessment of readiness to change occurred. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Readiness to change assessment date |
Valid date in MMDDCCYY format
|
analysis and use |
To determine the date of the readiness to change assessment To assist in determining whether the participant has received an assessment of readiness to change To facilitate analysis of changes in readiness to change for the participant and for the program over time |
|
Item 18b: RTC |
Participant Stage of Change This variable indicates the participant’s state of change based on a readiness to change assessment. |
|
SOURCE |
Prochaska, JO.; DiClemente, CC. The transtheroretical approach. In: Norcross, JC; Goldfried, MR. (eds.) Handbook of psychotherapy integration. 2nd ed. New York: Oxford University Press; 2005. p. 147–171. |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
1 Pre-contemplation |
Participant has little or no intention to change her behavior in the foreseeable future |
2 Contemplation |
Participant is thinking about making a change in her behavior |
|
3 Preparation |
Participant is ready to plan how she will make a change in her behavior |
|
4 Action |
Participant is in the process of trying to make a change in her behavior |
|
5 Maintenance |
Participant is trying to maintain a change she has made in her behavior |
|
8 Refused |
Participant refused to answer readiness to change assessment questions |
|
9 No answer recorded |
No answer was recorded |
|
analysis and use |
To assess participant’s stage of change based on a readiness to change assessment To facilitate analysis of changes in readiness to change for the participant and for the program over time To assist in assessments of participant behavior change outcomes in context of readiness to change |
|
Item 19a: RefDate |
Lifestyle Program (LSP) / Health Coaching (HC) Referral Date This variable indicates the date that a referral to a LSP/HC occurred. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
The denominator includes all WISEWOMAN participants |
|
VALUES and description |
Lifestyle Program/Health Coaching Referral Date |
Valid date in MMDDCCYY format
|
analysis and use |
To determine the date of the referral to a LSP/HC To assist in determining whether the participant has received a referral to a LSP/HC To assist in determining the number of LSP/HC referrals per participant To facilitate analysis of changes in LSP/HC referrals over time |
|
Item 20a: LSPHCRec |
Number of Lifestyle Program (LSP) / Health Coaching (HC) Sessions Received by the Participant This variable indicates the number of LSP/HC sessions the participant has received. |
|
Source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All LSP/HC sessions among WISEWOMAN participants |
|
VALUES and description |
Number of Sessions |
Value representing the number of LSP/HC sessions the participant has received (includes current LSP/HC session)
|
analysis and use |
To track the number of LSP/HC sessions that the participant has received To assess LSP/HC sessions in context of types and settings, and readiness to change of a participant |
|
Item 20b: Intervention
|
Date of Lifestyle Program (LSP) / Health Coaching (HC) Session For LSP/HC records, this variable indicates the date that the LSP/HC session occurred. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All LSP/HC sessions among WISEWOMAN participants
|
|
VALUES and description |
Lifestyle Program/Health Coaching Session Date |
Valid date in MMDDCCYY format
|
analysis and use |
To determine the date of the LSP/HC session To assist in determining whether the participant has received an LSP/HC session To assist in calculating the number of LSP/HC sessions per participant To assess whether participants with risk factors receive LSP/HC services To assess changes in risk profile between participants who participate in the LSP/HC and participants who do not |
|
Item 20c: LSPHCID |
Lifestyle Program (LSP) / Health Coaching (HC) ID This variable indicates which LSP/HC was used. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All LSP/HC sessions among WISEWOMAN participants |
|
VALUES and description |
Lifestyle Program ID |
Value representing the ID code of the LSP as assigned
|
Health Coaching ID |
Value representing the ID code of the HC as assigned |
|
analysis and use |
To track the number of WISEWOMAN participants who receive an LSP/HC session from each WISEWOMAN LSP/HC provider To describe differences in participant demographics or other characteristics by LSP/HC provider To identify the number of LSP/HC providers in a given geographic area |
|
Item 20d: LSPHCTime |
Length of Lifestyle Program (LSP) / Health Coaching (HC) Session Received by the Participant This variable indicates the length (in minutes) of the LSP/HC session the participant has received. |
|
Source |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All LSP/HC sessions among WISEWOMAN participants |
|
VALUES and description |
Length of Session |
Value representing the length of the LSP/HC session in minutes
|
analysis and use |
To track the length of the LSP/HC sessions that the participant has received To assess LSP/HC sessions in context of types and settings, and readiness to change of a participant |
|
Item 20e: ContactType |
Type of Lifestyle Program (LSP) / Health Coaching (HC) Session This variable indicates the type LSP/HC session. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All LSP/HC contacts among WISEWOMAN participants |
|
VALUES and description |
1 Face-to-face |
LSP/HC session was completed face-to-face |
2 Phone |
LSP/HC session was completed by phone |
|
|
3Smart phone/tablet Application |
LSP/HC session was completed with a smart phone or tablet application session. The program has received evidence that the application session was completed. |
|
4 Evidence that mailed materials were opened and reviewed |
LSP/HC session was completed by review of mailed materials. The program has received evidence that the materials were opened and reviewed |
|
5 Evidence that audiotape or DVD as opened and reviewed |
LSP/HC session was completed by review of an audiotape or DVD. The program has received evidence that the audiotape or DVD was opened and reviewed |
|
6 Evidence that non-interactive computer-based session was completed |
LSP/HC session was completed with a computer-based session that did not involve an interactive component. The program has received evidence that the computer-based session was completed |
7 Evidence that interactive computer-based session was completed |
LSP/HC session was completed with a computer-based session that involved an interactive component. The program has received evidence that the interactive computer-based session was completed. |
|
0 Other |
Other LSP/HC session type. |
|
99 No answer recorded |
No answer was recorded |
|
analysis and use |
To assess how frequently different types of LSP/HC sessions are being used within and across programs To determine whether frequency of LSP/HC session types are consistent with programs’ LSP models To assess LSP/HC sessions in context of types and settings, and readiness to change of a participant |
|
Item 20f: Setting |
Setting of Lifestyle Program (LSP) / Health Coaching (HC) Session This variable indicates the setting of the LSP/HC session. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All LSP/HC contacts among WISEWOMAN participants |
|
VALUES and description |
1 Individual |
LSP/HC contact for the participant occurred as an individual session |
|
2 Group |
LSP/HC contact for the participant occurred as a group session |
|
3 Combination
|
LSP/HC contact for the participant occurred as a combination of individual and group sessions |
9 No answer recorded |
No answer was recorded |
|
analysis and use |
To assess how frequently different types of LSP/HC settings are being used within and across programs To determine whether the settings of LSP/HC sessions are consistent with programs’ LSP/HC models To assess LSP/HC sessions in context of types and settings, and readiness to change of a participant |
|
Item 20g: LSPHCComp |
Completion of Lifestyle Program (LSP) / Health Coaching (HC) This variable indicates if the participant has completed the LSP/HC. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All WISEWOMAN participants participating in an LSP/HC program |
|
VALUES and description |
1 Yes – Lifestyle Program/Health Coaching is Complete |
Participant has completed the LSP/HC. An LSP requires multiple sessions, e.g., multiple sessions in a curriculum |
|
2 Yes – Intensive Follow-Up |
Participant is in intensive follow-up following LSP/HC completion |
3 No – Lifestyle Program/Health Coaching is still in progress |
Participant’s LSP/HC is still in progress |
|
4 No – Withdrawal/Discontinued |
Participant has withdrawn from the LSP/HC or discontinued the LSP/HC |
|
9 No answer recorded |
No answer was recorded for completion of LSP/HC |
|
analysis and use |
To determine whether the participant has completed an LSP/HC To assist in determining the date of the participant’s final LSP/HC session in the program To assess changes in risk profile between participants who complete the LSP/HC and participants who do not |
|
Item 21a: TobResDate
|
Date of Referral to Tobacco Cessation Resource This variable indicates the date that the referral to a tobacco cessation resource occurred. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All tobacco cessation resource referrals among WISEWOMAN participants
|
|
VALUES and description |
Tobacco Cessation Resource Referral Date |
Valid date in MMDDCCYY format
|
analysis and use |
To document the date of a referral to tobacco cessation resource To assist in tracking receipt of tobacco cessation resource |
|
Item 21b: TobResType |
Type of Tobacco Cessation Resource Activity This variable indicates the type of tobacco cessation resource activity that the participant was referred to. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All contacts among WISEWOMAN participants who identify themselves as current smokers |
|
VALUES and description |
1 Quit Line |
Participant was referred to a Proactive Tobacco Quit Line
|
2 Community-based tobacco program |
Participant was referred to a community-based tobacco program |
|
3 Other tobacco cessation resources |
Participant was referred to other tobacco cessation resources |
|
9 No answer recorded |
No answer was recorded |
|
analysis and use |
To determine the number of smokers that received a referral to tobacco cessation resource To determine how frequently different types of tobacco cessation resources are being used within and across programs To compare the smoking status at rescreening and follow-up of women who were linked to tobacco cessation resources versus those who were not |
|
Item21c:TobResComp |
Tobacco Cessation Resource Activity Completed This variable indicates whether the participant completed tobacco cessation resource activity. |
|
SOURCE |
Not applicable; WISEWOMAN-specific variable |
|
Denominator population |
All contacts among WISEWOMAN participants who identify themselves as current smokers |
|
VALUES and description |
1 Yes – Completed tobacco cessation resource activity |
Participant completed tobacco cessation resource activity
|
2 No – Partially completed tobacco cessation resource activity |
Participant partially completed tobacco cessation resource activity |
|
3 No – Withdraw from tobacco cessation resource activity when reached |
Participant withdrew/refused tobacco cessation resource activity when contacted |
|
4 No – Could not reach to conduct tobacco cessation resource activity |
Participant could not be reached when contacted by the tobacco cessation resource activity |
|
9 No answer recorded |
No answer was recorded |
|
analysis and use |
To determine the number of smokers that participated in tobacco cessation resource activities To compare the smoking status at rescreening and follow-up of women who were linked to tobacco cessation resources versus those who were not |
|
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Sasigant O'Neil |
| File Modified | 0000-00-00 |
| File Created | 2021-01-23 |
© 2025 OMB.report | Privacy Policy